About FDA

For Industry: Using Social Media

9/26/14 UPDATE:

In response to a request for additional time and to allow interested persons more time to submit comments, FDA is reopening the comment period for the two draft social media guidances that published on June 17, 2014.  Beginning September 29, 2014, the public will have an additional 30 days to provide comments on the drafts:
 

 

The Internet and various social media platforms have increasingly enabled drug and device manufacturers to more actively engage with consumers and healthcare professionals.

In November 2009, FDA held a Part 15 public hearing to gather comments and questions from our stakeholders (e.g., industry, health care professionals, consumers, patient groups, Internet vendors, advertising agencies, and other interested parties) on how FDA can best provide guidance on the promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools.

The public hearing was instrumental in providing an opportunity for our stakeholders to comment. In addition to the 77 live presentations, we received 72 comments to the docket—a major collaborative effort by both the Agency and our stakeholders.

OPDP carefully considered input received both from outside and within the Agency and has since released four draft guidances that address various topics related to the public hearing. We look forward to receiving stakeholder feedback in the near future on the two draft guidances that were released on June 17, 2014, and to continuing our work in this ever-evolving landscape.

 

Page Last Updated: 09/26/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.